FDA to allow import of oncology drug amid nationwide shortage
The FDA on June 2 told AHA that is has worked with Qilu Pharmaceuticals and Apotex Corp. to temporarily import cisplatin, a drug used in chemotherapy, after a national shortage. FDA said it is carefully assessing the overseas product for quality to ensure it is safe for U.S. patients. The agency issued a “Dear Health Care Provider” letter with details and updated its drug shortage database with more information.
Related News Articles
Headline
The House Energy and Commerce Committee held a hearing on legislative proposals to prevent and respond to generic drug shortages. In comments submitted…
Headline
AHA recently voiced support for four bipartisan bills introduced in the Senate to help alleviate the nation’s chronic and growing drug shortages.
…
News
Pfizer will ship certain sterile injectable products directly to customers under an emergency ordering process implemented yesterday due to high demand for the…
Headline
The Food and Drug Administration said it did not expect “any immediate significant impacts on supply” after a tornado damaged a Pfizer plant in North…
Headline
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…
Headline
AHA is weighing in on drug shortages that impact patient care in response to a request by Republican leaders in the House and Senate. Rep. Cathy McMorris…